Related Experiment Videos
[Lipiduria in the nephrotic syndrome].
Terapevticheskii Arkhiv
|January 1, 1992
Summary
Nephrotic syndrome (NS) increases blood lipids and urine lipid excretion. Chronic glomerulonephritis (CGN) and renal amyloidosis patients show distinct lipid profile changes, with CGN patients exhibiting specific phospholipid alterations in urine.
Area of Science:
- Nephrology
- Clinical Chemistry
- Biochemistry
Background:
- Nephrotic syndrome (NS) is characterized by significant proteinuria and lipid metabolism disturbances.
- Understanding lipid profiles in urine and blood is crucial for diagnosing and managing kidney diseases like chronic glomerulonephritis (CGN) and renal amyloidosis.
Purpose of the Study:
- To investigate and compare urine and blood lipid fractions in patients with NS due to CGN and renal amyloidosis.
- To identify specific lipid markers associated with different nephrotic conditions.
Main Methods:
- Analysis of total lipids (TL) and lipid fractions (phospholipids (PL), free cholesterol (FC), triglycerides (TG), cholesterol esters (CE)) in blood and urine.
- Comparison between 91 NS patients (CGN and renal amyloidosis subgroups), latent CGN patients, and healthy controls.
Main Results:
- NS patients exhibited elevated blood TL, FC, and TG, with decreased PL and CE, more pronounced in amyloidosis.
- Nephrotic lipiduria was marked by increased urine TL and PL, with PL changes being more characteristic of CGN.
- Elevated lipid filtration under nephrotic hyperlipidemia contributes to high urine lipid excretion.
Conclusions:
- NS is associated with significant alterations in blood and urine lipid profiles.
- Specific lipid fraction changes in urine may help differentiate between CGN and renal amyloidosis in NS.
- Local renal production of phospholipids plays a role in nephropathies involving inflammatory and membrane-destructive processes.